A Phase 3, Randomized, Double-blind, Placebo-controlled Study of ARD-101 for the Treatment of Hyperphagia in Patients with
Prader‑Willi Syndrome. More details coming soon.
© 2024 Aardvark Therapeutics, Inc. All Rights Reserved.
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of ARD-101 for the Treatment of Hyperphagia in Patients with
Prader‑Willi Syndrome. More details coming soon.